Jones RF - Search Results

1

Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.

Yong CS, Sharkey J, Duscio B, Venville B, Wei WZ, Jones RF, Slaney CY, Mir Arnau G, Papenfuss AT, Schröder J, Darcy PK, Kershaw MH. Yong CS, et al. Among authors: jones rf. PLoS One. 2015 Sep 3;10(9):e0136817. doi: 10.1371/journal.pone.0136817. eCollection 2015. PLoS One. 2015. PMID: 26334628 Free PMC article.

2

From breast cancer immunobiology to her-2 DNA vaccine and autoimmune sequelae.

Miller F, Jones RF, Jacob J, Kong YC, Wei WZ. Miller F, et al. Among authors: jones rf. Breast Dis. 2004;20:43-51. doi: 10.3233/bd-2004-20106. Breast Dis. 2004. PMID: 15687706 Review.

3

Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.

Jacob J, Radkevich O, Forni G, Zielinski J, Shim D, Jones RF, Wei WZ. Jacob J, et al. Among authors: jones rf. Cell Immunol. 2006 Apr;240(2):96-106. doi: 10.1016/j.cellimm.2006.07.002. Epub 2006 Aug 22. Cell Immunol. 2006. PMID: 16930573

4

An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice.

Jones RF, Reyes JD, Gibson HM, Jacob JB, Vaishampayan U, Ratner S, Chen K, Wei WZ. Jones RF, et al. Cancer Immunol Immunother. 2019 Jul;68(7):1143-1155. doi: 10.1007/s00262-019-02333-9. Epub 2019 Jun 8. Cancer Immunol Immunother. 2019. PMID: 31177328 Free PMC article.

5

Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.

Jacob JB, Quaglino E, Radkevich-Brown O, Jones RF, Piechocki MP, Reyes JD, Weise A, Amici A, Wei WZ. Jacob JB, et al. Among authors: jones rf. Cancer Res. 2010 Jan 1;70(1):119-28. doi: 10.1158/0008-5472.CAN-09-2554. Cancer Res. 2010. PMID: 20048073 Free PMC article.

6

Evolution of animal models in cancer vaccine development.

Wei WZ, Jones RF, Juhasz C, Gibson H, Veenstra J. Wei WZ, et al. Among authors: jones rf. Vaccine. 2015 Dec 16;33(51):7401-7407. doi: 10.1016/j.vaccine.2015.07.075. Epub 2015 Aug 1. Vaccine. 2015. PMID: 26241945 Free PMC article. Review.

7

Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.

Whittington PJ, Radkevich-Brown O, Jacob JB, Jones RF, Weise AM, Wei WZ. Whittington PJ, et al. Among authors: jones rf. Cancer Immunol Immunother. 2009 May;58(5):759-67. doi: 10.1007/s00262-008-0599-x. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836716 Free PMC article.

8

PEPMOTIF: a program for locating class I major histocompatibility complex restricted peptides in protein sequences.

Jones RF, Wei WZ. Jones RF, et al. J Immunol Methods. 1995 Feb 13;179(1):137-8. doi: 10.1016/0022-1759(94)00324-p. J Immunol Methods. 1995. PMID: 7868921

9

Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination.

Gibson HM, Veenstra JJ, Jones R, Vaishampayan U, Sauerbrey M, Bepler G, Lum L, Reyes J, Weise A, Wei WZ. Gibson HM, et al. Cancer Immunol Res. 2015 Jul;3(7):777-86. doi: 10.1158/2326-6066.CIR-14-0175. Epub 2015 Feb 23. Cancer Immunol Res. 2015. PMID: 25711535 Free PMC article.

10

DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies.

Whittington PJ, Piechocki MP, Heng HH, Jacob JB, Jones RF, Back JB, Wei WZ. Whittington PJ, et al. Among authors: jones rf. Cancer Res. 2008 Sep 15;68(18):7502-11. doi: 10.1158/0008-5472.CAN-08-1489. Cancer Res. 2008. PMID: 18794138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page